Atlas Trials

Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1,Chemotherapy and Target Therapy for Metastatic Colorectal Cancer

Clinical trial NCT06841159 · RECRUITING

Trial details

NCT number
NCT06841159
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Microsatellite Stable Metastatic Colorectal Cancer
Start date
2024-03-01
Primary completion
2026-03-01
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.